Hepatopulmonary syndrome

Miguel R. Arguedas, Michael B. Fallon

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


HPS occurs when pulmonary microvascular dilatation impairs arterial oxygenation in the setting of liver disease or portal hypertension. The syndrome is found in as many as 20% of cirrhotics and should be considered in any patient with chronic liver disease who develops dyspnea or hypoxemia. Recognition is important, because the presence of HPS increases mortality in the setting of cirrhosis. Contrast echocardiography and standard cardiopulmonary testing are generally sufficient to make the diagnosis of HPS, but further testing may be needed in patients who have both intrinsic cardiopulmonary disease and intrapulmonary vasodilatation. Treatment consists of supplemental oxygen and consideration of orthotopic liver transplantation if significant hypoxemia is present. The recognition in experimental models that a sequence of molecular alterations leads to endothelin-1 and TNF-α modulation of pulmonary microvascular tone may lead to the development of novel and effective medical therapies.

Original languageEnglish (US)
Pages (from-to)733-746
Number of pages14
JournalClinics in liver disease
Issue number4
StatePublished - Nov 2005

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Hepatopulmonary syndrome'. Together they form a unique fingerprint.

Cite this